Cattle Vaccine Market
- 2026 年市場規模
- USD 4.13 Bn
- 2033 年預估規模
- USD 6.17 Bn
- 年複合成長率 CAGR
- 5.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Cattle Vaccine Market, By Vaccine Type (Combination (Multivalent) Vaccines, Inactivated (Killed) Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and DNA / Vector-Based Vaccines), By Disease Indication (Bovine Respiratory Diseases (BRD Complex, IBR, BRSV, PI3), Foot and Mouth Disease (FMD), Clostridial Diseases (Blackleg, Enterotoxemia, Tetanus), Bovine Viral Diarrhea (BVD), Leptospirosis, Mastitis, Brucellosis, Anthrax, and Others (Johnes disease, Bluetongue, etc.)), By Cattle Type (Dairy Cattle, Beef Cattle, Breeding Stock, and Calves / Young Stock), By Route of Administration (Injectable Vaccines, Intranasal Vaccines, and Oral Vaccines), By End User (Commercial Dairy Farms, Beef Farms & Ranches, Veterinary Clinics & Hospitals, and Government & Institutional Vaccination Programs), By Distribution Channel (Direct Sales (Manufacturers to Farms/Institutions), Veterinary Hospitals & Clinics, Veterinary Pharmacies & Distributors, and Government Procurement Programs), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
According to Coherent Market Insights, the global cattle vaccine market is estimated to be valued at USD 4.13 Bn in 2026 and is expected to reach USD 6.17 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2026 to 2033. The global cattle vaccine market represents a critical segment of the veterinary healthcare industry, encompassing a comprehensive range of immunobiological products designed to prevent infectious diseases in cattle populations worldwide.
As livestock farming continues to evolve with increasing emphasis on animal health and welfare, cattle vaccines have become indispensable tools for maintaining herd immunity and ensuring sustainable agricultural productivity. These vaccines protect cattle against various bacterial, viral, and parasitic diseases including bovine respiratory disease complex, foot-and-mouth disease, brucellosis, anthrax, and clostridial infections, among others.
The market encompasses multiple vaccine types including live attenuated, inactivated, subunit, and recombinant vaccines, each serving specific therapeutic purposes and administration protocols. With the global population surge driving increased demand for protein-rich food sources, cattle farming operations are scaling up significantly, necessitating robust disease prevention strategies.
The market is characterized by continuous technological advancements in vaccine development, including novel adjuvants, improved delivery systems, and combination vaccines that offer broader protection spectrums. Regulatory frameworks across different regions ensure vaccine safety and efficacy, while veterinary professionals and livestock producers increasingly recognize the economic benefits of preventive healthcare measures over reactive treatment approaches, positioning cattle vaccines as essential components of modern animal husbandry practices.
Market Dynamics
The global cattle vaccine market is propelled by several compelling drivers that underscore its sustained growth trajectory. The primary driver stems from the escalating global demand for beef and dairy products, necessitating larger cattle populations and intensive farming practices that require comprehensive disease prevention strategies. Rising awareness about zoonotic diseases and their potential transmission from cattle to humans has intensified focus on livestock immunization programs, particularly in developing regions where cattle farming constitutes a significant economic activity.
Technological advancements in vaccine development, including the introduction of marker vaccines, thermostable formulations, and needle-free delivery systems, have enhanced vaccine efficacy and convenience, driving adoption rates among livestock producers.
Government initiatives and regulatory support for animal health programs, coupled with increasing veterinary healthcare expenditure, further accelerate market expansion. However, the market faces notable restraints including the high cost of vaccine development and regulatory approval processes, which can limit accessibility in price-sensitive markets. Cold chain storage requirements pose logistical challenges, particularly in remote agricultural regions with inadequate infrastructure.
Additionally, vaccine hesitancy among some livestock producers, concerns about potential adverse reactions, and the availability of alternative disease management approaches can impede market penetration. Nevertheless, significant opportunities emerge from expanding cattle farming operations in emerging economies, increasing adoption of precision livestock farming technologies, and growing emphasis on organic and antibiotic-free meat production. The development of next-generation vaccines utilizing recombinant DNA technology and nanotechnology platforms presents lucrative prospects, while strategic partnerships between vaccine manufacturers and livestock producers create new market channels and enhance distribution networks.
Key Features of the Study
• This report provides in-depth analysis of the global cattle vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cattle vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim Animal Health, Merck Animal Health MSD Animal Health, Elanco Animal Health, Ceva Santé Animale, HIPRA, Virbac, Vaxxinova, IDT Biologika, Biogénesis Bagó, Indian Immunologicals Ltd, Hester Biosciences Limited, Jinyu Bio-Technology Co Ltd, China Animal Husbandry Industry Co Ltd CAHIC, and Bioveta a.s. International
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cattle vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cattle vaccine market
Market Segmentation
• Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
o Combination (Multivalent) Vaccines
o Inactivated (Killed) Vaccines
o Live Attenuated Vaccines
o Recombinant Vaccines
o Toxoid Vaccines
o DNA / Vector-Based Vaccines
• Disease Indication Insights (Revenue, USD Bn, 2021 - 2033)
o Bovine Respiratory Diseases (BRD Complex, IBR, BRSV, PI3)
o Foot and Mouth Disease (FMD)
o Clostridial Diseases (Blackleg, Enterotoxemia, Tetanus)
o Bovine Viral Diarrhea (BVD)
o Leptospirosis
o Mastitis
o Brucellosis
o Anthrax
o Others (Johne’s disease, Bluetongue, etc.)
• Cattle Type Insights (Revenue, USD Bn, 2021 - 2033)
o Dairy Cattle
o Beef Cattle
o Breeding Stock
o Calves / Young Stock
• Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
o Injectable Vaccines
o Intranasal Vaccines
o Oral Vaccines
• End User Insights (Revenue, USD Bn, 2021 - 2033)
o Commercial Dairy Farms
o Beef Farms & Ranches
o Veterinary Clinics & Hospitals
o Government & Institutional Vaccination Programs
• Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
o Direct Sales (Manufacturers to Farms/Institutions)
o Veterinary Hospitals & Clinics
o Veterinary Pharmacies & Distributors
o Government Procurement Programs
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Zoetis
o Boehringer Ingelheim Animal Health
o Merck Animal Health MSD Animal Health
o Elanco Animal Health
o Ceva Santé Animale
o HIPRA
o Virbac
o Vaxxinova
o IDT Biologika
o Biogénesis Bagó
o Indian Immunologicals Ltd
o Hester Biosciences Limited
o Jinyu Bio-Technology Co Ltd
o China Animal Husbandry Industry Co Ltd CAHIC
o Bioveta a.s. International
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Cattle Vaccine Market, By Vaccine Type
Global Cattle Vaccine Market, By Disease Indication
Global Cattle Vaccine Market, By Cattle Type
Global Cattle Vaccine Market, By Route of Administration
Global Cattle Vaccine Market, By End User
Global Cattle Vaccine Market, By Distribution Channel
Global Cattle Vaccine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Cattle Vaccine Market, By Vaccine Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Combination (Multivalent) Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Inactivated (Killed) Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Live Attenuated Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Recombinant Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Toxoid Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o DNA / Vector-Based Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Cattle Vaccine Market, By Disease Indication, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Bovine Respiratory Diseases (BRD Complex, IBR, BRSV, PI3)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Foot and Mouth Disease (FMD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Clostridial Diseases (Blackleg, Enterotoxemia, Tetanus)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Bovine Viral Diarrhea (BVD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Leptospirosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Mastitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Brucellosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Anthrax
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others (Johne’s disease, Bluetongue, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Cattle Vaccine Market, By Cattle Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Dairy Cattle
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Beef Cattle
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Breeding Stock
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Calves / Young Stock
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Cattle Vaccine Market, By Route of Administration, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Injectable Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Intranasal Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Oral Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Cattle Vaccine Market, By End User, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Commercial Dairy Farms
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Beef Farms & Ranches
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Veterinary Clinics & Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Government & Institutional Vaccination Programs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Cattle Vaccine Market, By Distribution Channel, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Direct Sales (Manufacturers to Farms/Institutions)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Veterinary Hospitals & Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Veterinary Pharmacies & Distributors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Government Procurement Programs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Cattle Vaccine Market, By Region, 2021 - 2033, Value (USD Bn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
o South Africa
o North Africa
o Central Africa
11. Competitive Landscape
o Zoetis
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Boehringer Ingelheim Animal Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck Animal Health MSD Animal Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Elanco Animal Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Ceva Santé Animale
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o HIPRA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Virbac
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Vaxxinova
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o IDT Biologika
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Biogénesis Bagó
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Indian Immunologicals Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Hester Biosciences Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Jinyu Bio-Technology Co Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o China Animal Husbandry Industry Co Ltd CAHIC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bioveta a.s. International
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
12. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
13. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on 'Cattle Vaccine Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們